ER-β shows strong anti-proliferative [97,98] and anti-inflammatory properties [99], and it is detected more frequently in patients with chronic liver disease than those with HCC [32], which implicates a protective role of ER-β in liver disease. Here, ESR2 is linked to hepatocellular carcinoma.